AmeXio Group, a global leader in structured content management (SCM) and enterprise content management (ECM) solutions, is ...

Small, 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to ...

Organ-on-a-chip systems offer a more accurate, ethical, and scalable alternative to animal testing in drug discovery and ...

NEW YORK, July 3, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the secure ...

The nonprofit that operates Shriners Children's hospitals across North America will locate a $153 million medical research ...

As part of the transaction, Oragenics issued 660,000 shares of its Series H Convertible Preferred Stock, no par value, together with Warrants to purchase up to 660,000 additional shares of Series H ...

Technology is changing faster than ever. Business owners often struggle to keep up. What''s trending today might be outdated ...

Quantum plasmonic biosensors enable self-illumination for real-time, label-free diagnostics with scalable point-of-care applications.

A new cancer detection test to analyze volatile organic compounds through urine analysis, was granted the Breakthrough Device Designation status by the U.S. FDA. The system, which is built on gas ...

As Medadvisor's divestment deal today attests, foreign acquirers are on the hunt for undervalued local assets.